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Letter to the Editor 
 
Becoming patient-centred: sobering insight into CPE-positive patients’ experiences of 
clinical care 
 
 
Sir, 
 
As recently reviewed in this journal by French et al,1  there is expanding literature regarding 
carbapenemase-producing Enterobacteriaceae (CPE) outbreaks, control measures and their 
effectiveness. These papers report the number of cases (CPE infection or colonization) 
involved in outbreaks, multi-component infection control measures including patient 
screening; contact precautions (e.g. gowns, gloves); cohorting of patients; and patient 
isolation. However, there is scant mention of how a CPE diagnosis and subsequent treatment 
can impact patients’ lives.   
 
University Hospital Limerick (UHL) was, in 2011, the site of the first Irish CPE outbreak;2 
since then, we have reported both outbreaks and their management, with emphasis placed on  
clinical parameters.3-5 However, in the context of quality improvement (QI) we recognised 
that there was a gap in our knowledge relating, specifically, to the experience of those 
patients central to our CPE incidences.6 
 
Concurrent with members of our infection control team participating in a Royal College of 
Physicians of Ireland (RCPI)-delivered QI Diploma, UHL experienced an increase in newly-
identified CPE-positive patients between June and August 2015. This increase provided 
subject matter for an opportunistic project based on the premise that the social aspects of 
isolation have been determined in previous research papers,7-9 but that the perspectives of 
CPE-positive Irish patients had not been captured previously. Cognisant that even a cursory 
internet search can readily identify multiple alarmist stories of  “superbugs”, ineffective drugs 
of last resort  and associated deaths leading, in the event of a CPE diagnosis, to increased 
distress and anxietyfor both patients and their families, we sensitively surveyed such patients 
using a series of open ended questions.  
The outcomes were sobering. While patients expressed a high level of satisfaction with the 
physical design of our newly-established Infection Control Cohort Ward, they were confused 
by communication to them of their CPE and the explanatory leaflets provided to them. 
Further, they used emotive terms such as “Leper”, “Pariah” and “Plague” to describe  their 
treatment by staff, demonstrating clearly the need for consistent, effective education of 
healthcare professionals regarding multidrug-resistant organisms and holistic needs of 
affected patients.  
 
We as healthcare professionals often do not look beyond specimens and infection control 
aspects of managing patients with CPE.  However, the impact of a CPE diagnosis on patients 
and their families should not be underestimated as it influences both their subsequent quality 
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of life and future aspirations and, in many cases, involves ongoing engagement with medical 
treatment and hospitalisations. Listening to the voices of those receiving our care is just the 
beginning. The challenge is to use these narratives to improve practice and the patient 
experience. 
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